Treatment Intensity in the Frontline Setting for Transplant-Ineligible Patients With Multiple Myeloma - Quiz - MDSpire

Treatment Intensity in the Frontline Setting for Transplant-Ineligible Patients With Multiple Myeloma

The management of newly diagnosed transplant-ineligible multiple myeloma remains challenging, in part due to the complexity of treatment decisions for frail patients. Recent subgroup analyses provide insight into whether quadruplet therapy may offer advantages over triplet therapy in this population.

  • By

  • Mark Davis

  • May 6, 2026

  • 18 min

Share

Original Source(s)

Treatment Intensity in the Frontline Setting for Transplant-Ineligible Patients With Multiple Myeloma

  • by Mark Davis

  • May 6, 2026

Related Content

Retraction: MicroRNA-935 directly targets FZD6 to inhibit the proliferation of human glioblastoma and correlate to glioma malignancy and prognosis

  • May 28, 2026

Outcomes of critically ill pediatric patients after haploidentical stem cell transplantation

Case Report: Acute myeloid leukemia with mixed immunophenotypic features and TCF3::ZNF384 fusion in a pediatric patient with CNS involvement: a diagnostic and therapeutic challenge